| Website | bioscale.com |
| Category | BioTech |
| Phone | 1.617.301.6000 |
| Employees | |
| Description | Biomolecular detection |
| Total | $45.7M |
| Unattributed, 12/07 Blackfin Technology | $20.7M |
| Series D, 6/10 Morningside Venture Investments New Science Ventures WFD Ventures F2 Ventures | $25M |
BioScale, Inc., is a life science tools company that has developed a proprietary and platform for life sciences and diagnostics. The company develops products that enable ultra-sensitive, quantitative measurements scaling a wide range of biological analytes and complex matrices.
At the core of BioScale’s capabilities is the BioMEMS-based Acoustic Membrane and Microparticle (AMMP™) technology. AMMP technology provides picogram-level detection that outperforms the existing gold standard.
